ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

BCDA BioCardia Inc

2.90
-0.03 (-1.02%)
27 6월(6) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
BioCardia Inc BCDA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.03 -1.02% 2.90 05:24:31
개장가 저가 고가 종가 전일 종가
2.96 2.62 2.96 2.90 2.93
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
07/06/202420:00GLOBEBioCardia Announces United States Patent Issuance on..
22/05/202406:00GLOBEBioCardia Announces Reverse Stock Split
15/05/202405:02GLOBEBioCardia Reports First Quarter 2024 Business Highlights and..
01/05/202420:00GLOBEBioCardia’s CardiAMP Cell Therapy Chronic Myocardial..
25/04/202422:00GLOBEBioCardia Completes Enrollment of CardiAMP Cell Therapy for..
28/03/202405:00GLOBEBioCardia Reports Fourth Quarter and Full Year 2023 Business..
20/03/202420:00GLOBEBioCardia to Host 2023 Financial Results and Corporate..
13/03/202420:00GLOBEBioCardia and StemCardia Announce Biotherapeutic Delivery..
12/03/202420:00GLOBEBioCardia Announces CMS Approval of Coverage for CardiAMP..
04/03/202422:00EDGAR2Form 8-K - Current report
04/03/202422:00GLOBEBioCardia Reports Positive Interim Results from Phase III..
28/02/202406:53EDGAR2Form SC 13D/A - General statement of acquisition of..
15/02/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202407:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:17EDGAR2Form S-3 - Registration statement under Securities Act of..
09/02/202423:58EDGAR2Form 8-K - Current report
08/02/202421:03EDGAR2Form 8-K - Current report
08/02/202421:00GLOBEBioCardia Announces Activation of CardiAMP Heart Failure II..
07/02/202406:28EDGAR2Form SC 13D/A - General statement of acquisition of..
03/02/202404:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/01/202421:00EDGAR2Form 8-K - Current report
31/01/202421:00GLOBEBioCardia Announces Two Scientific Abstracts Have Been..
03/01/202421:00EDGAR2Form 8-K - Current report
03/01/202421:00GLOBEBioCardia Biotherapeutic Delivery and Morph Access..
19/12/202321:00EDGAR2Form 8-K - Current report
19/12/202321:00GLOBEBioCardia Doses First Patient in CardiALLO Phase I/II..
18/12/202321:16GLOBEBioCardia Announces Expected CardiAMP Heart Failure Japan..
18/12/202321:00EDGAR2Form 8-K - Current report
06/12/202320:05EDGAR2Form 8-K - Current report
06/12/202320:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
06/12/202306:11EDGAR2Form 8-K/A - Current report: [Amend]
06/12/202306:05EDGAR2Form 8-K - Current report
29/11/202321:00EDGAR2Form 8-K - Current report
29/11/202321:00GLOBEBioCardia Shares Update from Japan PMDA Consultation on..
18/11/202307:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/11/202307:15EDGAR2Form 8-K - Current report
17/11/202302:56GLOBEBioCardia Announces $1.3 Million Registered Direct Offering..
14/11/202321:15GLOBEBioCardia Announces FDA Approval of CardiAMP Heart Failure..
09/11/202306:11GLOBEBioCardia Reports Third Quarter 2023 Business Highlights and..
09/11/202306:08EDGAR2Form 8-K - Current report
09/11/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202306:04GLOBEBioCardia to Host Q3 2023 Corporate Update and Financial..
20/10/202322:26EDGAR2Form S-3 - Registration statement under Securities Act of..
20/10/202306:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202306:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202306:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202306:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202306:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202306:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..